Cell Viability Assays Market Growth 2022-2028: Rising Global Prevalence of Chronic and Infectious Diseases

The global Cell Viability Assays Market size was USD 3.26 Billion in 2020 and is expected to register a CAGR of 8.7% during the forecast period. Rising prevalence of chronic and infectious diseases, increasing focus on cell-based therapeutics, and growing private and public funding for cell-based research studies are key factors expected to drive market revenue growth over the forecast period.

Rapid rise in chronic diseases such as heart disease, obesity, diabetes, and cancer due to sedentary lifestyle, rapid urbanization, unhealthy dietary habits, and growing geriatric population is expected boost adoption of cell viability assays in research to develop efficient treatment and diagnostic methods. In addition, increasing advancements in stem cell research is expected to further contribute to revenue growth of the market over the forecast period.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4084

Key players in the market include:

Thermo Fisher Scientific, Inc., Agilent Technologies Inc., Bio-Rad Laboratories, Becton, Dickinson and Company, Merck KGaA, GE Healthcare, BioTek Instruments, PerkinElmer, Inc., Promega Corporation, Biotium, Abcam Plc., Canvax, Danaher Corporation, and Creative Bioarray.

Cell viability assays in research studies are carried out to determine overall health of cells, optimize conditions of experiments, and to study the survival rate of cells after treatment with experimental compounds such as drugs. Cell viability assays provide information about cell health through measurement of the metabolic activity of cells, ATP synthesis and storage, or cell proliferation. Cell viability can also be understood through cell toxicity assays that determine markers of cell death. Cell viability and cell toxicity assays are critical tools for assessing cellular responses to experimental compounds and reagents. Viability assays have been widely used to study the efficacy of substances in reducing impact of toxic substances and this has boosted its adoption in stem cell and cancer research to produce cell-based and anti-cancer therapeutics.

Rising expenditure in healthcare sector and increasing research and development activities in the biopharmaceutical sector are factors expected to drive market growth. Cell viability assays are also imperative in quality control experiments in food and beverage, pharmaceuticals, biotechnology, and water treatment industries. This is expected to drive revenue growth of the market over the forecast period. However, high costs of equipment and more time taken by cell viability assays are expected to restrain market growth to a certain extent over the forecast period.

Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/cell-viability-assays-market
 

Some Key Highlights From the Report:

  • Consumables segment is expected to register significant revenue growth during the forecast period owing to increasing demand for consumables such as assay kits, reagents, and microplates in cell viability experiments in stem cell and cancer research.
  • Drug discovery and development segment is expected to account for considerably large revenue share in the global market between 2021 and 2028. Increasing prevalence of chronic and infectious diseases have boosted demand for effective therapeutic approaches and growing financial support from governments for development of novel drugs and therapeutics are expected to contribute significantly to revenue growth of this segment.
  • Pharmaceutical and biotechnology companies segment is expected to register rapid revenue CAGR during the forecast period owing to increasing focus on stem cell research, rising investment in biopharmaceutical R&D, and growing application of cell viability assays in drug discovery and development.
  • North America is expected to account for largest market share in terms of revenue during the forecast period owing to increasing private and public funding for stem cell and cancer research, rising demand for biologics, and presence of state-of-the-art healthcare and research infrastructure in the region.

Download Summary @ https://www.reportsanddata.com/download-summary-form/4084

For the purpose of this report, Reports and Data has segmented the global cell viability assays market based on product, application, end-use industry, and region:  

Product Outlook (Revenue, USD Billion; 2018-2028)

  • Consumables
    • Reagents
    • Assay Kits
      • Tetrazolium Reduction Assay Kits
      • MTT Assay Kits
      • Other Tetrazolium Assay Kits
      • Resazurin Cell Viability Assay Kits
      • Calcein-AM Cell Viability Assay Kits
      • Other Assay Kits
    • Microplates
  • Instruments
    • Spectrophotometers
    • Flow Cytometers
    • Automated Cell Counters
    • Cell Imaging & Analysis Systems

Application Outlook (Revenue, USD Billion; 2018-2028)

  • Basic Research
  • Stem Cell Research
  • Drug Discovery & Development
  • Clinical and Diagnostics
  • Others

End-use Outlook (Revenue, USD Billion; 2018-2028)

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Labs
  • Academic & Research Institutes
  • Others

Regional Outlook (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/4084

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times. According to market experts, the pandemic has turned this industry upside down, with an unprecedented rise in demand and acute supply shortage. The report clearly depicts the current global economic landscape and the considerable situation of the healthcare industry. A substantial increase in demand for healthcare services worldwide, rising cases of the SARS-CoV-2 infection, increasing pharmaceutical research & development activities, and new drug pipelines are among the key factors that have driven the global pharma & healthcare industry growth in the recent past. Growing acceptance of telehealth and telemedicine services, rise in government initiatives for COVID-19 vaccine development, and escalating demand for advanced point-of-care diagnostics and home healthcare products have further bolstered the industry growth.

Explore Latest Trending Research Reports By Reports and Data's:

Microcatheters Market By Product Type (Delivery, Aspiration, Diagnostic, Steerable, and Others), By Product Design (Single Lumen and Dual Lumen), By Application (Cardiology, Neurology, Peripheral Vascular, Oncology, Urology, Otolaryngology, and Others), By End-Use (Hospital, Surgical Centers, Specialty Clinics, and Ambulatory Surgical Centers), and By Region Forecast to 2028

Pharmaceutical Grade Sodium Chloride Market , By Product Type (API-NaCl, HD-NaCl), By Application (Channeling Agents/Osmotic Agent, Mechanical Cleansing Solutions, Peritoneal Dialysis, Hemofiltration Solutions, Injections, Hemodialysis, Oral Rehydration Salts, Others), and By Region Forecast to 2028

Bone Allografts and Xenografts Market By Product Type (Allografts, Xenografts, and Others), By Application (Spinal Fusion, Bone Trauma, and Others), and By Region Forecast to 2028

Enteric Empty Capsules Market Size, Share & Growth By Type (Gelatin Type, HPMC Type, Vegetable Other), By Application (Antacid and Antiflatulent Preparations, Antibiotic and Antibacterial Drugs), By End Use (Pharmaceutical, Health Supplements, Others), And Region Forecast To 2028

Ofloxacin Eye Drop Market , By Type (Ophthalmic surgery, Anti-inflammatory, Others), By Application (Adult, Children, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies. Online Pharmacies, Others), and By Region Forecast to 2028

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

 

Back to news